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1408-1) ~~g~xjdelnhib~~n ln~rea*~ln~ulin ~en~itiviW
R. Butler,A.D. Morris, A.D. Struthers. University Department of Clinical
Pharmacology Ninewells Hospital and Medical School, Dundee, DD1 9W
UK
Recent evidence has suggested that endothelial nitric oxide synthesis and
insulin sensitivity are associated in humans. We have examined this hypoth-
esis directly by evaluating the effects of systemic NO inhibition on whole
body insulin sensitivity in human subjects. 16 normal subjects attended on 2
study days to evaluate the effects of a 3 hour infusion of the nitric oxide syn-
thase inhibitor, NG-monomethyl-L-arginineacetate (L-NMMA, 3 mg/k@hour)
or plaoetm on whole body insulin sensitivity and calf blood flow (CBF) using
the euglycaemic hyparinsulinaemlc clamp and bilateral calf venous occlusion
piethyamography. L-NMMAwes associated with a weak pre$eoreffecf, asig-
nificant negative chronotropic response and a significant increase in whola
body gluCOSeupfake. Whoie body insulin sensitivity during the clamp was9.4
+ 2.9 and 10.9+ 3.2 rng/k@minfor placebo and L-NMMA, respectively (p =
0.03; 95% Cl 0.2, 2.6). L-NMMA increased calf blood flow by 30% compared
with placebo; for exampla, at 180 minutes values were 1.6 + 0.8 and 2.0 +
0.8 ml/100 mldmin for placebo and L-NMMA, respectively.These data show
for the first time that systemic inhibition of nitric oxide synthesis increases
whole My insulin sensitivity. Our results are contrary to pravious repotis
which have uaed local intra-arfenal infusion techniques and which suggested
that endotheiial nitric oxide synthesis and insulin sensitivity are positively
related. Systemic inhibition of NO may selectively redistribute blood flow re-





A.S, Coenar, N. Protonotarios, A. Tsatsopoulou, E.W.A. Needham,
V.A. Murday, R.S. Houlston, S. Cliff, Ml. Otter, R.K. Mattu, W.J. McKenna.
St. George’s Hospital Medical School, London, UK, YannisProtonotarios
Medical Centre, Nsxos, Greece
Arrhythmogenic right ventricular cardiomyopathy (ARVC) causes sudden
death, amhythmiaa,and heart failure. Familial disease is common and three
loci have been reported for autosomal dominant forms of the disease. A
major difficulty in asseasing the genetic basis of the disease is an apparently
high rate of non-penetranoe and variable expression which makes diagnosis
difficult, and phenotypic copies due to other causes.
Protonotarloa identified the phenotypa of Naxos syndrome (ARVC + pal-
moplantar keratodefma + woolly hair) which racently has been denoted to
be a distinct clinical entity (McKusick #801214*). We evaluated the popu-
lation of Naxos, Greece. From a total population of approximately 20,000;
eleven affected families of 148 persons were identified. 21 had Nexos syn-
drome. Segregation analysis identified autosomal recessive inheritance.The
disease had high penetrance and expression, and thus represented an ex-
cellent model to investigate the genetic basis of ARVC.
In 40 family members molecular genetic analysis was performed. Radio-
Iabelled short-sequence repeat markere were resolved on denaturing poly-
acrylsmide gels. The loci for the autosomal dominant forms of the disease
were excluded. Subsequently, following a candidate gene search strategy,
a marker which co-aggregated exclusively with the diseaae in a recessive
manner and mapped to 17plq3 was identified. The peak 2 point Iod score
was 4.07 at O= O.
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1408-3] Thraa-Dimensionsl~ransesoPha@al
Echocardiographyfor Determining AorticVslve Area
in Velvular Aortic Stenoeis: A Prospective Clinical
Study
S. Ge, J.G. Warner, Jr., T.P.Abraham, N.D. Ken, R.F.Brooker, A.M. Nomeir,
K.M. Fowle, P.Burgess, D.W. Kitzman.
Current methods forasseasing aorfic valve area (AVA)have wall-known the-
oretical and practical limitations. In order to investigate the potential of three-
dimensional (3D) echocardiography for determining AVA in vaivular aortic
stenosis (AS), intraoperative transesophageal echocardiography (TEE) was
perlormed in 17 consecutive patients using a TomTec EchoScan system in-
terfaced with a Toshiba 380A and a mukiplane TEE probe. 3DE images of
the AVwere processed and displayad using a ‘surgeon’s aortotomy view’. 2D
images were displayed using.the best mid-esophageal views of AV. For both
3D and 2D images, AVAwas measured by electronic planimetry of the inner
edge of the AV leaflets during the maximal systolic opening. Although imper-
fect, for practical reasons the Goriin formula (by cardiac cath) and continuity
equation (by Doppler) methods were used as ‘standards’ for comparison.
Resu/ts: 3D AVA measurements were feasible in all but 1 patient. Regres-
sion coefficient (r), standard error (SEE), and mean difference (mdif, cm2, by
Bland-Altman) + SD vs. reference methods were:
Gorlinformula Continuityequation
2D r = 0.67, SEE = 0,7; mdif= 0,4 + 0.7 r= 0.S3, SEE = 0.6; mdif= 0.5 + 0.6
3D r= 0.66, SEE= 0.4; mdif= 0.1 + 0.4 r= 0.91, SEE= 0,3; mdif= 0.0& 0.3
Compared to 2D TEE AVA, 3D TEE AVA had better agreement and had
significantly smaller mean differences from the Gorlin formula (p < 0.02) and
mntinuity equation (p < 0.0004). Conclusion.’ 3D determination of AVA is




A.C. Skanes, A.S.L. Tang. University of Ottawa Heart /nstitute, Ottawa,
Canada
Phasic modulation of atrioventricular nodal (AVN) conduction has not ~n
described in humans. The objectives of this study were to demonstrate
ventriculophasic modulation of AV node (VPAVN), and to substantiate the
role of baroreflex on VPAVN conduction by pharmacologic perturbation of
parasympathetic tone.
Twelve patients (pts), 7 males, mean age of 70 + 14 yrs who presentad
with 2Qheart block were studied. After informed conaent, cathetenswere lm-
sitioned at the high RA and His. All pts had ventriculopahsic sinus arrhythmia
(VPSA) with sinus cycle length variation of 44 + 18 ms, and infra-His block.
Incremental atrial pacing was performed until AV nodal Wenckebach (W) at
baseline, after phenylepherine (P) infusion, and after atropine (A) in sufficient
dosage to abolish VPSA.
At baseline, mean sinus cycle length was 644 + 189 ms. VPAVN was
presant in 9 of 12 pts and at the steep portion of the AVN conduction curves.
P was infused in all but 3 hypertensive pts which increased SBP by 27.6%
to 1~ +22 mm Hg (p < 0.001), and sinus cycle length by 19.7% to 1010
* 190 ms (p < 0.001). W point increased by 14.4% from 386 i 93 ms to
441 + 119 ms (p= 0.03). VPAVN was noted in 8of 9 pts who received P. P
brought out VPAVNin 2 of 3 pts in whom it waa not present at baseline. In the
pt in whom no VPAVN was present, P had no effect on the AVN conduction
curve. A shortenad sinus cycle length by 33% to 656 + 109 ms (p c 0.001),
reduced W point to 334 + 65 ms (p = 0.003). A abolished both VPSA and
VPAVN in all pts.
Conclusion: This study demonstrated ventriculophasic modulation of AV
nodal conduction in pts with 2Qinfra-His heart block. This phenomenon waa
accentuated by P and abolished by A, strongly suggesting a baroreflex
mechanism for VPSA and VPAVNconduction.
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1408-51Generation and Maintenan~aof Reentrant~ave
Fronts during Ventricular Fibrillation in Human
Hesrts with Dilated Cardiomyopathy: Role of
Nonuniform Aniaotropy
T.-J.Wu, J.J.C. Ong, C. Hwang, J.J. Lee, M.C. Fishbein, L. Czer, A. Trento,
C. Blanche, W.J. Mandel, H.S. Karaguezian, P.-S.Chen. Cedars-Sinai
Medical Center and UCLA, Los Angeles, CA, USA
To test the hypothesis that morphologic changes from disease prooesa may
contribute to the generation and maintenance of reentry (R) during VF, 6
hearts from transplant recipients with dilated cardiomyopathy (DCM) were
mapped. The hearts were supported by Lengendorff-perfusion immediately
after explanation. A plaque electrode array (32 x 38 mm) with 477 bipolar
electrodes (1,6 mm interelectrode distance) was used for epicardial map-
ping. In heatt #5, we also used 440 transmurai bipolar recordings (110
plunge electrodes, 5 mm between adjacent plunges, 1.5 mm interelectrode
distance) for 3-D mapping. A total of 18 runs of VF (8 secJrun) recorded
from epicardiumwere analyzed. Excluding the 3 runs from heart #6 (treated
with amiodarone), 55 episodes of R were observed. The life span of R was
.
